BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11743282)

  • 1. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma.
    Martins AC; Faria SM; Cologna AJ; Suaid HJ; Tucci S
    J Urol; 2002 Jan; 167(1):89-92; discussion 92-3. PubMed ID: 11743282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
    J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
    Zhu Y; Zhou XY; Yao XD; Dai B; Ye DW
    BJU Int; 2007 Jul; 100(1):204-8. PubMed ID: 17433031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma?
    Guimarães GC; Leal ML; Campos RS; Zequi Sde C; da Fonseca FP; da Cunha IW; Soares FA; Lopes A
    Urology; 2007 Jul; 70(1):137-42. PubMed ID: 17656224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between lymph node density and disease specific survival in patients with penile cancer.
    Svatek RS; Munsell M; Kincaid JM; Hegarty P; Slaton JW; Busby JE; Gaston KE; Spiess PE; Pagliaro LC; Tamboli P; Pettaway CA
    J Urol; 2009 Dec; 182(6):2721-7. PubMed ID: 19837433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder.
    Fleshner N; Kapusta L; Ezer D; Herschorn S; Klotz L
    J Urol; 2000 Oct; 164(4):1177-82. PubMed ID: 10992361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
    J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
    Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
    Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
    Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.
    Hamel NW; Sebo TJ; Wilson TO; Keeney GL; Roche PC; Suman VJ; Hu TC; Podratz KC
    Gynecol Oncol; 1996 Aug; 62(2):192-8. PubMed ID: 8751548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute.
    Ornellas AA; Nóbrega BL; Wei Kin Chin E; Wisnescky A; da Silva PC; de Santos Schwindt AB
    J Urol; 2008 Oct; 180(4):1354-9. PubMed ID: 18707720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
    Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
    Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes.
    Theodorescu D; Russo P; Zhang ZF; Morash C; Fair WR
    J Urol; 1996 May; 155(5):1626-31. PubMed ID: 8627839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.